Robotic surgery gets a sense of touch: can it make prostate cancer operations safer?

NCT ID NCT07247175

Recruiting now Symptom relief Sponsor: Seong Soo Jeon Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new feature on the da Vinci 5 surgical robot that gives surgeons a sense of touch during prostate cancer surgery. 60 patients will take part, with surgeons randomly using the force feedback on or off. The goal is to see if this helps surgeons learn faster and reduces tissue damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: da Vinci 5 robotic system with force feedback
What this could lead to: If successful, this could show that force feedback makes robotic surgery safer and easier to learn, potentially improving outcomes for prostate cancer patients.
What could go wrong: This is a small, early-phase study with only 60 patients at one center. The benefits seen may not apply to all surgeons or hospitals, and the force feedback may not significantly improve safety or learning.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICALLY LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Samsung Medical Center
RECRUITING

Soeul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.